Chinese Center for Disease Control and Prevention
China's national public health institution for disease prevention, surveillance, research, health promotion, and emergency response.
Last updated October 9, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
The Chinese Center for Disease Control and Prevention, commonly known as China CDC, is a national public health institution based in Changping District, Beijing, and operating directly under China's National Health Commission. Established in 1983, it supports the country's disease-prevention system through epidemiological surveillance, laboratory science, public-health research, technical guidance, health education, and emergency response. Its remit covers infectious diseases as well as environmental health, occupational health and safety, chronic-disease prevention, health promotion, and public-health education. China CDC works with provincial and local health authorities and with other domestic and international organizations. Its role is principally institutional and scientific rather than commercial: it collects and analyzes health information, develops and disseminates technical guidance, supports outbreak investigation, operates or administers public-health laboratories, and contributes to national prevention programs. The organization also publishes and co-sponsors professional journals, including China CDC Weekly, Journal of Hygiene Research, Chinese Journal of Experimental and Clinical Virology, and Chinese Journal of Epidemiology. These publications provide channels for epidemiological findings, laboratory research, surveillance reports, and public-health analysis. The center became especially visible internationally during the COVID-19 pandemic. On 10 January 2020, it uploaded the genetic sequence of SARS-CoV-2 to the Global Initiative on Sharing All Influenza Data, enabling broader international access to the sequence. In 2022, it shared a phylogenetic analysis with GISAID concerning more than 32 independent introductions of SARS-CoV-2 from outside China identified during the first quarter of that year. The institution also administers or supports laboratories in China, including a biosafety level 2 facility at the Wuhan Center for Disease Control. That facility has sometimes been conflated in public discussion with the separate Wuhan Institute of Virology; the two are distinct institutions. China CDC also contributes to professional training. Its Chinese Vaccinology Course has been conducted in partnership with the University of Chinese Academy of Sciences and the Bill & Melinda Gates Foundation. The center's work therefore spans operational public health, scientific research, workforce development, communication, and coordination across China's disease-control network. A workforce description from 2016 reported 2,120 staff members, including 1,876 technical professionals, 133 managerial staff, and 111 logistics staff. Shen Hongbing is identified as the current director in the referenced material.
History
The Chinese Center for Disease Control and Prevention was established in 1983 as a national institution supporting China's disease-prevention and public-health infrastructure. It is headquartered in Changping District, Beijing, and is directly under the National Health Commission. Rather than operating as a consumer-facing brand or commercial enterprise, China CDC functions as a technical and scientific body within the national health system. Its responsibilities developed around the core functions of a modern national public-health agency. These include disease surveillance, epidemiological investigation, infectious-disease prevention and control, laboratory research, environmental-health assessment, occupational safety and health, health promotion, and prevention education. The center provides information intended to improve health decisions and works with provincial health departments and other organizations to apply public-health measures throughout China. Its activities include both routine prevention and support during health emergencies. China CDC administers or works through a network of public-health laboratories. One facility associated with the Wuhan Center for Disease Control is a biosafety level 2 laboratory. During the COVID-19 pandemic, media attention to this facility sometimes led to confusion with the Wuhan Institute of Virology, which is a separate institution. The distinction is important because China CDC's Wuhan facility and the Wuhan Institute of Virology are not the same organization. The center's international visibility increased sharply during the COVID-19 pandemic. On 10 January 2020, it made the SARS-CoV-2 genetic sequence available through GISAID. Sharing the sequence enabled researchers and public-health laboratories to use it in comparative analysis and related scientific work. In 2022, China CDC also shared with GISAID a phylogenetic analysis concerning more than 32 independent introductions of SARS-CoV-2 from outside China that had been identified during the first quarter of that year. Education and professional development form another part of the institution's work. China CDC operates the Chinese Vaccinology Course in partnership with the University of Chinese Academy of Sciences and the Bill & Melinda Gates Foundation. This reflects its role in building technical capacity in vaccination and immunization science rather than merely publishing outbreak information. The center is also a publisher and sponsor of professional scientific literature. The referenced material identifies 16 journals that China CDC publishes or co-sponsors, including China CDC Weekly, Journal of Hygiene Research, Chinese Journal of Experimental and Clinical Virology, and Chinese Journal of Epidemiology. These publications support the communication of surveillance results, epidemiological studies, laboratory findings, and other public-health research. A 2016 workforce description recorded 2,120 staff members. Of these, 1,876 were technical professionals, 133 were managerial staff, and 111 worked in logistics. The figures illustrate the center's predominantly scientific and technical composition. Shen Hongbing is identified in the referenced material as its current director. China CDC remains an active component of China's public-health administration, linking national policy, scientific evidence, laboratory capability, professional training, and local disease-control operations.
- 2022
Phylogenetic analysis was shared with GISAID
[1]The center shared an analysis of more than 32 independent SARS-CoV-2 introductions from outside China identified during the first quarter of 2022.
- 2020
SARS-CoV-2 sequence was shared through GISAID
[1]China CDC uploaded the genetic sequence of SARS-CoV-2 to GISAID on 10 January 2020 for broader international scientific access.
- 2016
Workforce profile documented
[1]A workforce description reported 2,120 staff members, including 1,876 technical professionals, 133 managerial employees, and 111 logistics staff.
- 1983
China CDC was established
[1]The Chinese Center for Disease Control and Prevention was established as a national institution for disease prevention, public-health research, surveillance, and technical support.
Products and positioning
A national, science-based public-health institution that coordinates disease prevention, surveillance, laboratory research, health promotion, and emergency response within China's health system.
public-health publication
China CDC Weekly
A professional publication associated with China CDC that disseminates epidemiological information, surveillance findings, outbreak reports, and other public-health research. It serves researchers, health officials, and practitioners who need current evidence about disease patterns and prevention in China.
professional training
Chinese Vaccinology Course
A vaccinology education and capacity-building program operated in partnership with the University of Chinese Academy of Sciences and the Bill & Melinda Gates Foundation. The course reflects China CDC's role in developing technical expertise related to vaccines and immunization.
public-health infrastructure
Public-health laboratory and surveillance services
China CDC supports laboratory research, epidemiological surveillance, disease investigation, and technical response across China's disease-control system. These capabilities address infectious diseases and also extend to environmental health, occupational health, prevention, and health promotion.
Marketing campaigns
- Chinese Vaccinology Course
China
A professional education initiative conducted with the University of Chinese Academy of Sciences and the Bill & Melinda Gates Foundation to strengthen vaccinology knowledge and public-health capacity.
Brand decisions
2022
Sharing of a SARS-CoV-2 introduction analysisOtherBackground
China CDC analyzed viral sequences associated with cases identified during the first quarter of 2022.
Action taken
The center shared with GISAID a phylogenetic analysis covering more than 32 independent introductions from outside China.
Aftermath
The analysis became part of the international scientific record available through GISAID.
2020
Release of the SARS-CoV-2 genetic sequenceOtherBackground
The emergence of COVID-19 created an urgent need for researchers and public-health laboratories to access the virus's genetic information.
Action taken
China CDC uploaded the SARS-CoV-2 genetic sequence to GISAID on 10 January 2020.
Aftermath
The sequence became available for international scientific analysis and supported subsequent research and public-health work.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/chinese-center-for-disease-control-and-prevention · Editorial policy · How profiles are compiled